Microcirculatory dysfunction in the heart and the brain

Minerva Cardioangiologica

Volumn 67, Issue 4, 2019, Pages 318-329

  Mejía Rentería, Hernán ^a   Matias Guiu, Jordi A ^a   Lauri, Francesco ^a   Yus, Miguel ^a   Escaned, Javier ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Brain; Cerebral small vessel diseases; Cognitive dysfunction; Dementia; Heart; Myocardial ischemia

Indexed keywords

ACETYLCHOLINE; CALCIUM; CYCLIC GMP; GUANOSINE TRIPHOSPHATE; NITRIC OXIDE; SOMATOMEDIN C;

ACUTE CORONARY SYNDROME; ALL CAUSE MORTALITY; ALZHEIMER DISEASE; AUTOREGULATION; BLOOD BRAIN BARRIER; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BRAIN ATROPHY; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; CAPILLARY RAREFACTION; CARDIAC GRAFT REJECTION; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY FLOW RESERVE; CORONARY MICROCIRCULATORY DYSFUNCTION; DIABETES MELLITUS; DIFFUSION TENSOR IMAGING; ENDOTHELIAL DYSFUNCTION; FRACTIONAL ANISOTROPY; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOXIA; MICROANGIOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REVIEW; SHEAR STRESS; SUSCEPTIBILITY WEIGHTED IMAGING; SYNDROME X; THROMBOSIS; VASCULAR AMYLOIDOSIS; VASODILATATION; BRAIN CIRCULATION; COGNITIVE DEFECT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; HEART MUSCLE ISCHEMIA; MICROCIRCULATION; PHYSIOLOGY; RISK FACTOR;

CEREBRAL SMALL VESSEL DISEASES; CEREBROVASCULAR CIRCULATION; COGNITIVE DYSFUNCTION; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; HUMANS; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; NEURODEGENERATIVE DISEASES; RISK FACTORS;

EID: 85070577557     PISSN: 00264725     EISSN: 18271618     Source Type: Journal    
DOI: 10.23736/S0026-4725.18.04701-1     Document Type: Review

References (99)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al.; Writing Group Members; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics-2016 Update: AReport From the American Heart Association. Circulation 2016;133:447-54.
2. Marzilli M, Merz CN, Boden WE, Bonow RO, Capozza PG, Chilian WM, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol 2012;60:951-6.
3. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J 2012;33:2771-2782b.
4. Chade AR, Brosh D, Higano ST, Lennon RJ, Lerman LO, Lerman A. Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney Int 2006;69:266-71.
5. Mohandas R, Segal MS, Huo T, Handberg EM, Petersen JW, Johnson BD, et al. Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia. PLoS One 2015;10:e0125374.
6. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, et al. Retinal arteriolar narrowing and risk of cor onary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA2002;287:1153-9.
7. Arbel Y, Sternfeld A, Barak A, Burgansky-Eliash Z, Halkin A, Berliner S, et al. Inverse correlation between coronary and retinal blood flows in patients with normal coronary arteries and slow coronary blood flow. Atherosclerosis 2014;232:149-54.
8. Komaru T, Kanatsuka H, Shirato K. Coronary microcirculation: physiology and pharmacology. Pharmacol Ther 2000;86:217-61.
9. Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 1986;251:H779-88.
10. Kassab GS, Lin DH, Fung YC. Morphometry of pig coronary venous system. Am J Physiol 1994;267:H2100-13.
11. Jones CJ, Kuo L, Davis MJ, Chilian WM. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 1995;29:585-96.
12. Hainsworth AH, Oommen AT, Bridges LR. Endothelial cells and human cerebral small vessel disease. Brain Pathol 2015;25:44-50.
13. Kuschinsky W, Paulson OB. Capillary circulation in the brain. Cerebrovasc Brain Metab Rev 1992;4:261-86.
14. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JLJr. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978;234:H371-83.
15. Kulik T, Kusano Y, Aronhime S, Sandler AL, Winn HR. Regulation of cerebral vasculature in normal and ischemic brain. Neuropharmacology 2008;55:281-8.
16. Blanco PJ, Müller LO, Spence JD. Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease. Stroke Vasc Neurol 2017;2:108-17.
17. Chen BR, Kozberg MG, Bouchard MB, Shaik MA, Hillman EM. Acritical role for the vascular endothelium in functional neurovascular coupling in the brain. J Am Heart Assoc 2014;3:e000787.
18. Hillman EM. Coupling mechanism and significance of the BOLDsignal: a status report. Annu Rev Neurosci 2014;37:161-81.
19. Horiuchi T, Dietrich HH, Hongo K, Dacey RGJr. Mechanism of extracellular K+-induced local and conducted responses in cerebral penetrating arterioles. Stroke 2002;33:2692-9.
20. Ngai AC, Nguyen TS, Meno JR, Britz GW. Postischemic augmentation of conducted dilation in cerebral arterioles. Stroke 2007;38:124-30.
21. Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol 2013;304:H1598-614.
22. Pries AR, Reglin B. Coronary microcirculatory pathophysiology: can we afford it to remain a black box? Eur Heart J 2017;38:478-88.
23. Mejía-Rentería H, van der Hoeven N, van de Hoef TP, Heemelaar J, Ryan N, Lerman A, et al. Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests. Int J Cardiovasc Imaging 2017;33:1041-59.
24. Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology 1997;138:3515-20.
25. Tarantini S, Tucsek Z, Valcarcel-Ares MN, Toth P, Gautam T, Giles CB, et al. Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. Age (Dordr) 2016;38:273-89.
26. Sokolova IA, Manukhina EB, Blinkov SM, Koshelev VB, Pinelis VG, Rodionov IM. Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension. Microvasc Res 1985;30:1-9.
27. Mulvany MJ. Vascular remodelling of resistance vessels: can we define this? Cardiovasc Res 1999;41:9-13.
28. De Silva TM, Faraci FM. Microvascular Dysfunction and Cognitive Impairment. Cell Mol Neurobiol 2016;36:241-58.
29. Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, et al. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J 2015;36:3134-46.
30. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989;13:968-72.
31. Mulvany MJ. Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol 2012;110:49-55.
32. Rizzoni D, De Ciuceis C, Porteri E, Paiardi S, Boari GE, Mortini P, et al. Altered structure of small cerebral arteries in patients with essential hypertension. J Hypertens 2009;27:838-45.
33. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. NEngl J Med 2003;349:1027-35.
34. Escaned J, Flores A, García-Pavía P, Segovia J, Jimenez J, Aragoncillo P, et al. Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts. Circulation 2009;120:1561-8.
35. Sorop O, Merkus D, de Beer VJ, Houweling B, Pistea A, McFalls EO, et al. Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis. Circ Res 2008;102:795-803.
36. Hong H, Aksenov S, Guan X, Fallon JT, Waters D, Chen C. Remodeling of small intramyocardial coronary arteries distal to a severe epicardial coronary artery stenosis. Arterioscler Thromb Vasc Biol 2002;22:2059-65.
37. Bekkers SC, Smulders MW, Passos VL, Leiner T, Waltenberger J, Gorgels AP, et al. Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging. Eur Radiol 2010;20:2572-8.
38. Beek AM, Nijveldt R, van Rossum AC. Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging 2010;26:49-55.
39. Hamirani YS, Wong A, Kramer CM, Salerno M. Effect of microvascular obstruction and intramyocardial hemorrhage by CMRon LVremodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC Cardiovasc Imaging 2014;7:940-52.
40. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-9.
41. Bai J, Lyden PD. Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema. Int J Stroke 2015;10:143-52.
42. Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J 2013;34:2346-53.
43. Hossmann KA. Reperfusion of the brain after global ischemia: hemodynamic disturbances. Shock 1997;8:95-101.
44. Hill RA, Tong L, Yuan P, Murikinati S, Gupta S, Grutzendler J. Regional Blood Flow in the Normal and Ischemic Brain Is Controlled by Arteriolar Smooth Muscle Cell Contractility and Not by Capillary Pericytes. Neuron 2015;87:95-110.
45. Dalkara T, Arsava EM. Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? J Cereb Blood Flow Metab 2012;32:2091-9.
46. Gursoy-Ozdemir Y, Yemisci M, Dalkara T. Microvascular protection is essential for successful neuroprotection in stroke. J Neurochem 2012;123(Suppl 2):2-11.
47. Hollander MR, de Waard GA, Konijnenberg LS, Meijer-van Putten RM, van den Brom CE, Paauw N, et al. Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction. PLoS One 2016;11:e0157233.
48. Su Q, Nyi TS, Li L. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. Cochrane Database Syst Rev 2015;(5):CD009503.
49. Félétou M, Köhler R, Vanhoutte PM. Nitric oxide: orchestrator of endothelium-dependent responses. Ann Med 2012;44:694-716.
50. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA1999;282:2035-42.
51. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Respir Cell Mol Biol 1993;8:1-6.
52. Matsuda K, Teragawa H, Fukuda Y, Ueda K, Higashi Y, Sakai K, et al. Response of the left anterior descending coronary artery to acetylcholine in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 2003;92:1394-8.
53. Ong P, Athanasiadis A, Mahrholdt H, Borgulya G, Sechtem U, Kaski JC. Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol 2012;101:673-81.
54. Marzilli M, Sambuceti G, Fedele S, L'Abbate A. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol 2000;35:327-34.
55. Bakker SL, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MM. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999;52:578-83.
56. Terborg C, Gora F, Weiller C, Röther J. Reduced vasomotor reactivity in cerebral microangiopathy : a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke 2000;31:924-9.
57. Stevenson SF, Doubal FN, Shuler K, Wardlaw JM. Asystematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010;41:e434-42.
58. Li Y, Yang D, Lu L, Wu D, Yao J, Hu X, et al. Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention. Can J Cardiol 2015;31:989-97.
59. Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dys function and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012;126:1858-68.
60. van de Hoef TP, Bax M, Damman P, Delewi R, Hassell ME, Piek MA, et al. Impaired Coronary Autoregulation Is Associated With Long-term Fatal Events in Patients With Stable Coronary Artery Disease. Circ Cardiovasc Interv 2013;6:329-35.
61. Lee JM, Jung JH, Hwang D, Park J, Fan Y, Na SH, et al. Coronary Flow Reserve and Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis. J Am Coll Cardiol 2016;67:1158-69.
62. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, et al.; National Institutes of Health- National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:2993-9.
63. Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012;33:734-44.
64. Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015;131:19-27.
65. Camici PG, d'Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol 2015;12:48-62.
66. Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol 2016;1:83-92.
67. Wardlaw JM, Allerhand M, Doubal FN, Valdes Hernandez M, Morris Z, Gow AJ, et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology 2014;82:1331-8.
68. Valdés Hernández Mdel C, Maconick LC, Muñoz Maniega S, Wang X, Wiseman S, Armitage PA, et al.;. Acomparison of location of acute symptomatic vs. 'silent' small vessel lesions. Int J Stroke 2015;10:1044-50.
69. Uh J, Yezhuvath U, Cheng Y, Lu H. In vivo vascular hallmarks of diffuse leukoaraiosis. J Magn Reson Imaging 2010;32:184-90.
70. Sam K, Crawley AP, Poublanc J, Conklin J, Sobczyk O, Mandell DM, et al. Vascular Dysfunction in Leukoaraiosis. AJNRAm J Neuroradiol 2016;37:2258-64.
71. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, et al.; LADIS group. Longitudinal cognitive decline in subcortical ischemic vascular disease-the LADIS Study. Cerebrovasc Dis 2009;27:384-91.
72. Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA2009;302:627-37.
73. Østergaard L, Aamand R, Gutiérrez-Jiménez E, Ho YC, Blicher JU, Madsen SM, et al. The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging 2013;34:1018-31.
74. Zhang X, Le W. Pathological role of hypoxia in Alzheimer's disease. Exp Neurol 2010;223:299-303.
75. Nielsen RB, Egefjord L, Angleys H, Mouridsen K, Gejl M, Møller A, et al. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease. Alzheimers Dement 2017;13:1143-53.
76. Yew B, Nation DA; Alzheimer's Disease Neuroimaging Initiative. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia. Brain 2017;140:1987-2001.
77. Janota C, Lemere CA, Brito MA. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease. Mol Neurobiol 2016;53:3793-811.
78. Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005;111:2291-8.
79. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 2008;585:97-108.
80. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005;64:277-81.
81. Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, et al. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology 2005;64:1358-65.
82. Toda N, Okamura T. Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview. J Clin Pharmacol 2013;53:1228-39.
83. Prieto D, Contreras C, Sánchez A. Endothelial dysfunction, obesity and insulin resistance. Curr Vasc Pharmacol 2014;12:412-26.
84. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545-51.
85. Fontbonne A, Berr C, Ducimetière P, Alpérovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001;24:366-70.
86. Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: does age make a difference? Hypertension 2004;44:631-6.
87. Chuang YF, Eldreth D, Erickson KI, Varma V, Harris G, Fried LP, et al. Cardiovascular risks and brain function: a functional magnetic resonance imaging study of executive function in older adults. Neurobiol Aging 2014;35:1396-403.
88. Granger DN, Rodrigues SF, Yildirim A, Senchenkova EY. Microvascular responses to cardiovascular risk factors. Microcirculation 2010;17:192-205.
89. Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. BioMed Res Int 2014;2014:406960.
90. Adamski MG, Sternak M, Mohaissen T, Kaczor D, Wierońska JM, Malinowska M, et al. Vascular Cognitive Impairment Linked to Brain Endothelium Inflammation in Early Stages of Heart Failure in Mice. J Am Heart Assoc 2018;7:e007694.
91. Huang AL, Vita JA. Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med 2006;16:15-20.
92. Recio-Mayoral A, Mason JC, Kaski JC, Rubens MB, Harari OA, Camici PG. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J 2009;30:1837-43.
93. Dhawan SS, Corban MT, Nanjundappa RA, Eshtehardi P, McDaniel MC, Kwarteng CA, et al. Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Atherosclerosis 2012;223:384-8.
94. Fu Y, Yan Y. Emerging Role of Immunity in Cerebral Small Vessel Disease. Front Immunol 2018;9:67.
95. Walker KA, Power MC, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, et al. Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study. Stroke 2017;48:3196-202.
96. de Roos A, van der Grond J, Mitchell G, Westenberg J. Magnetic Resonance Imaging of Cardiovascular Function and the Brain: Is Dementia a Cardiovascular-Driven Disease? Circulation 2017;135:2178-95.
97. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004;109:568-72.
98. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al.; CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. NEngl J Med 2017;377:1119-31.
99. Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ; CANTOS Trial Group. Effect of interleukin- 1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 2017;390:1833-42.